Takeda, along with Lundbeck and Advocate Health Care, will study an app to track and measure patients’ experience on antidepressant therapies.
Teva, the world's largest generics maker, is looking to form a Chinese joint venture with local company Guangzhou Pharma.
Three major regulatory bodies – FDA, EMA and Health Canada – changed their guidelines to drug naming. How could these changes impact drug launch timelines?
Amgen is expanding its cancer and inflammation biosimilar presence in China with a new deal with Simcere.
AstraZeneca rolled out positive results for a LAMA/LABA that could help the company gain a respiratory foothold in Asia.
Gilead Sciences has received approval for Sovaldi from China's FDA, gaining a foothold in the world's largest hepatitis C market.
Big Pharma expanded in emerging markets by 6.1% last quarter, but GSK and Eli Lilly didn't reap as much growth as their peers
It’s dance time for Astellas’ new ad campaign. The company has partnered up with the ABC show “Dancing with the Stars” for its newest Myrbetriq push.
The forces of competition are mounting against Humira, the world’s best-selling drug at $16 billion in global sales, with approval of a second biosimilar in…
GSK has formed an alliance with China’s e-commerce giant Alibaba to help promote HPV vaccine Cervarix.
Remember Doan’s for back pain? It's back, thanks to Dr. Reddy’s Laboratories, which is breathing new marketing life into a handful of older brands.